175 related articles for article (PubMed ID: 23608548)
1. Funding resources for rare disease research.
Stehr F; Forkel M
Biochim Biophys Acta; 2013 Nov; 1832(11):1910-2. PubMed ID: 23608548
[TBL] [Abstract][Full Text] [Related]
2. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic perspectives in the neuronal ceroid lipofuscinoses.
Kmoch S; Stránecký V; Emes RD; Mitchison HM
Biochim Biophys Acta; 2013 Nov; 1832(11):1831-41. PubMed ID: 23274885
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials in rare disease: challenges and opportunities.
Augustine EF; Adams HR; Mink JW
J Child Neurol; 2013 Sep; 28(9):1142-50. PubMed ID: 24014509
[TBL] [Abstract][Full Text] [Related]
5. Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.
Bozorg S; Ramirez-Montealegre D; Chung M; Pearce DA
Surv Ophthalmol; 2009; 54(4):463-71. PubMed ID: 19539834
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens.
Anderson GW; Smith VV; Brooke I; Malone M; Sebire NJ
Ultrastruct Pathol; 2006; 30(5):373-8. PubMed ID: 17090516
[TBL] [Abstract][Full Text] [Related]
7. The neuronal ceroid-lipofuscinoses: a historical introduction.
Haltia M; Goebel HH
Biochim Biophys Acta; 2013 Nov; 1832(11):1795-800. PubMed ID: 22959893
[TBL] [Abstract][Full Text] [Related]
8. Use of model organisms for the study of neuronal ceroid lipofuscinosis.
Bond M; Holthaus SM; Tammen I; Tear G; Russell C
Biochim Biophys Acta; 2013 Nov; 1832(11):1842-65. PubMed ID: 23338040
[TBL] [Abstract][Full Text] [Related]
9. Future perspectives: What lies ahead for Neuronal Ceroid Lipofuscinosis research?
Cooper JD; Mole SE
Biochim Biophys Acta Mol Basis Dis; 2020 Sep; 1866(9):165681. PubMed ID: 31926264
[TBL] [Abstract][Full Text] [Related]
10. Juvenile neuronal ceroid lipofuscinosis and education.
von Tetzchner S; Fosse P; Elmerskog B
Biochim Biophys Acta; 2013 Nov; 1832(11):1894-905. PubMed ID: 23470553
[TBL] [Abstract][Full Text] [Related]
11. Future perspectives: Moving towards NCL treatments.
Cotman SL; Mole SE; Kohan R
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2336-8. PubMed ID: 25857620
[TBL] [Abstract][Full Text] [Related]
12. Cardiac involvement in juvenile neuronal ceroid lipofuscinosis (Batten disease).
Ostergaard JR; Rasmussen TB; Mølgaard H
Neurology; 2011 Apr; 76(14):1245-51. PubMed ID: 21464428
[TBL] [Abstract][Full Text] [Related]
13. Moving towards therapies for juvenile Batten disease?
Cooper JD
Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
[TBL] [Abstract][Full Text] [Related]
14. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.
Ragbeer SN; Augustine EF; Mink JW; Thatcher AR; Vierhile AE; Adams HR
J Child Neurol; 2016 Mar; 31(4):481-7. PubMed ID: 26336202
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
Tokola AM; Salli EK; Åberg LE; Autti TH
Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
[TBL] [Abstract][Full Text] [Related]
16. Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses.
Warrier V; Vieira M; Mole SE
Biochim Biophys Acta; 2013 Nov; 1832(11):1827-30. PubMed ID: 23542453
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic landscape for Batten disease: current treatments and future prospects.
Johnson TB; Cain JT; White KA; Ramirez-Montealegre D; Pearce DA; Weimer JM
Nat Rev Neurol; 2019 Mar; 15(3):161-178. PubMed ID: 30783219
[TBL] [Abstract][Full Text] [Related]
18. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.
Cooper JD
Curr Opin Neurol; 2003 Apr; 16(2):121-8. PubMed ID: 12644737
[TBL] [Abstract][Full Text] [Related]
19. Human pathology in NCL.
Anderson GW; Goebel HH; Simonati A
Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
[TBL] [Abstract][Full Text] [Related]
20. Cataract and glaucoma development in juvenile neuronal ceroid lipofuscinosis (batten disease).
Nielsen AK; Drack AV; Ostergaard JR
Ophthalmic Genet; 2015 Mar; 36(1):39-42. PubMed ID: 25365415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
